Thiosemicarbazone-benzenesulfonamide Derivatives as Human Carbonic Anhydrases Inhibitors: Synthesis, Characterization, and <i>In silico</i> Studies

Author(s):

Muhammed Trawally, Kübra Demir-Yazıcı, Andrea Angeli*, Kerem Kaya, Atilla Akdemir, Claudiu T. Supuran and Özlen Güzel-Akdemir*   Pages 649 - 667 ( 19 )

Abstract:

Introduction: Carbonic anhydrases (CAs) are widespread metalloenzymes with the core function of catalyzing the interconversion of CO₂ and HCO₃ -. Targeting these enzymes using selective inhibitors has emerged as a promising approach for the development of novel therapeutic agents against multiple diseases. <p> Methods: A series of novel thiosemicarbazone-containing derivatives were synthesized, characterized, and tested for their inhibitory activity against pharmaceutically important human CA I (hCA I), II (hCA II), IX (hCA IX), and XII (hCA XII) using the single tail approach. <p> Results: The compounds generally inhibited the isoenzymes at low nanomolar concentrations, with compound 6b having K_i values of 7.16, 0.31, 92.5, and 375 nM against hCA I, II, IX and XII, respectively. Compound 6e exhibited K_i values of 27.6, 0.34, 872, and 94.5 nM against hCA I, II, IX and XII, respectively. <p> Conclusion: To rationalize the inhibition data, molecular docking studies were conducted, providing insight into the binding mechanisms, molecular interactions, and selectivity of the compounds towards the isoenzymes.

Keywords:

Carbonic anhydrase, benzenesulfonamide, thiosemicarbazones, tail approach, molecular docking, in silico studies.

Affiliation:

Graphical Abstract:

Read Full-Text article